Literature DB >> 32594359

Co-administration of Aluminum Sulfate and Propolis Regulates Matrix Metalloproteinases-2/9 Expression and Improves the Uterine Leiomyoma in Adult Rat Model.

Behpour Yousefi1,2, Vahid Semnani3, Tahmineh Mokhtari4, Sam Zarbakhsh1,5, Mohammad Hasan Tabrizi Amjad2,4, Mehdi Barati6, Hoda Doustmohammadi7,8.   

Abstract

The aim of this study was to evaluate the effects of aluminum sulfate (alum) with propolis (PR) on uterine leiomyoma (UL) in rat model. One hundred and four female Wistar rats (180-200 g) were allocated into two main groups of control (Co, n = 8) and experiment (UL model [estradiol benzoate 200 μg/kg/IM twice/week/8 weeks] with/without treatment) defined in 13 subgroups with/without treatment with coil oil (UL + COi), PR (100 or 200 mg/kg) as UL + PR100 or 200, alum (35, 75 or 150 mg/Kg) as UL + AL 35, 75, or 150, and PR (100 mg/kg or 200) with alum (35, 75, or 150 mg/Kg) as UL + PR100 or 200 + AL35, 75, or 150. Subgroups received doses of therapeutics for 14 days (IP). In the end, rats were sacrificed, and the uteri were isolated for molecular and histopathological investigations. The myometrium thickness, collagen contents, and gene expression of MMP-2 and 9 increased significantly in experimental groups with/without treatment (P ˂ 0.05). PR administration (100 and 200 mg/kg) alone or with alum (35 and 75 mg/kg) significantly decreased myometrium collagen contents and the gene expression and protein concentration of MMP-2 and 9 compared with UL and UL + Coi subgroups (P ˂ 0.05). Alum (75 mg/kg) with PR (200 mg/kg) could improve UL features and reduce MMP-2 and 9 gene expression.

Entities:  

Keywords:  Aluminum sulfate; Matrix metalloproteinases; Propolis; Rat; Uterine leiomyoma

Mesh:

Substances:

Year:  2020        PMID: 32594359     DOI: 10.1007/s12011-020-02200-0

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  28 in total

Review 1.  Uterine myomas: an overview of development, clinical features, and management.

Authors:  Edward E Wallach; Nikos F Vlahos
Journal:  Obstet Gynecol       Date:  2004-08       Impact factor: 7.661

Review 2.  Etiology, symptomatology, and diagnosis of uterine myomas.

Authors:  William H Parker
Journal:  Fertil Steril       Date:  2007-04       Impact factor: 7.329

Review 3.  New directions in the epidemiology of uterine fibroids.

Authors:  Shannon K Laughlin; Jane C Schroeder; Donna Day Baird
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

4.  Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.

Authors:  Xin Wu; Vanida A Serna; Justin Thomas; Wenan Qiang; Michael L Blumenfeld; Takeshi Kurita
Journal:  Cancer Res       Date:  2017-10-20       Impact factor: 12.701

5.  Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.

Authors:  E A Stewart; A J Friedman; K Peck; R A Nowak
Journal:  J Clin Endocrinol Metab       Date:  1994-09       Impact factor: 5.958

Review 6.  The extracellular matrix contributes to mechanotransduction in uterine fibroids.

Authors:  Phyllis C Leppert; Friederike L Jayes; James H Segars
Journal:  Obstet Gynecol Int       Date:  2014-07-03

7.  An engineered PD-1-based and MMP-2/9-oriented fusion protein exerts potent antitumor effects against melanoma.

Authors:  Mulan Wei; Xujie Liu; Chunyu Cao; Jianlin Yang; Yafeng Lv; Jiaojiao Huang; Yanlin Wang; Ye Qin
Journal:  BMB Rep       Date:  2018-11       Impact factor: 4.778

8.  Advanced 3D Imaging of Uterine Leiomyoma's Morphology by Propagation-based Phase-Contrast Microtomography.

Authors:  Alessandra Giuliani; Stefania Greco; Serena Pacilè; Alessandro Zannotti; Giovanni Delli Carpini; Giuliana Tromba; Stefano Raffaele Giannubilo; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

9.  Comparison of the inhibitory effect of gonadotropin releasing hormone (GnRH) agonist, selective estrogen receptor modulator (SERM), antiprogesterone on myoma cell proliferation in vitro.

Authors:  Youn-Jee Chung; Boah Chae; Se-Hyun Kwak; Jae-Yen Song; Ah-Won Lee; Hyun-Hee Jo; Young-Ok Lew; Jang-Heub Kim; Mee-Ran Kim
Journal:  Int J Med Sci       Date:  2014-01-28       Impact factor: 3.738

Review 10.  Uterine fibroid management: from the present to the future.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Hum Reprod Update       Date:  2016-07-27       Impact factor: 15.610

View more
  1 in total

Review 1.  Mineral medicine: from traditional drugs to multifunctional delivery systems.

Authors:  Xiaoqing Zhong; Zhenning Di; Yuanxin Xu; Qifan Liang; Kuanhan Feng; Yuting Zhang; Liuqing Di; Ruoning Wang
Journal:  Chin Med       Date:  2022-02-10       Impact factor: 5.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.